disease interaction(s) of obesity with diabetes mellitus type 2
Jump to navigation
Jump to search
Laboratory
- increased serum IL-6 in patients newly diagnosed with type 2 diabetes is associated with an increased risk of obesity-related cancer[1]
- obesity increases risk of hepatic fibrosis in patient with type 2 diabetes[2]
- 14% of young adults with obesity & type 2 diabetes have hepatic fibrosis on elastography[2]
Management
- bariatric surgery (gastric bypass or sleeve gastrectomy) reduces post-operative health care expenses in obese type-2 diabetics primarily due to reductions in pharmacy expenditures[3]
More general terms
References
- ↑ Jump up to: 1.0 1.1 Bhattacharya S A Simple Blood Test May Predict Cancer Risk in T2D. Medscape. September 11, 2024 https://www.medscape.com/viewarticle/simple-blood-test-may-predict-cancer-risk-t2d-2024a1000gh4
- ↑ Jump up to: 2.0 2.1 2.2 Sharma A, Godina Leiva E, Kalavalapalli S et al Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen. Obesity (Silver Spring). 2024 Oct;32(10):1967-1974. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39315409
- ↑ Jump up to: 3.0 3.1 Maciejewski ML, Zepel L, Smith VA et al Health Expenditures of Patients With Diabetes After Bariatric Surgery: Comparing Gastric Bypass and Sleeve Gastrectomy. Ann Intern Med. 2025 Jan 28. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39869915 https://www.acpjournals.org/doi/10.7326/ANNALS-24-00480